U.S. Semiconductors Stock News

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Mesa Laboratories, Inc. ( NASDAQ:MLAB ) will pay a dividend of $0.16 on the 16th of March. The dividend yield will be...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Crane (NYSE:CR) has had a great run on the share market with its stock up by a significant 13% over the last three...

The board of Jefferies Financial Group Inc. ( NYSE:JEF ) has announced that it will pay a dividend on the 27th of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Despite an already strong run, Hawaiian Electric Industries, Inc. ( NYSE:HE ) shares have been powering on, with a gain...

Brookfield Infrastructure stock snapshot Brookfield Infrastructure (BIPC) shares have retreated over the past month and past 3 months, with the stock closing at US$43.26. This may prompt investors to reassess the company’s current valuation and fundamentals. See our latest analysis for Brookfield Infrastructure. BIPC’s recent 1 month share price return of a 6.63% decline and 3 month share price return of a 5.07% decline contrast with a 1 year total shareholder return of 18.58%, suggesting...

In recent days, Jim Cramer repeatedly described SI-BONE as a “great, great speculation” on air, drawing attention to its minimally invasive sacropelvic implants and broader musculoskeletal device portfolio. His comments, combined with fresh analyst coverage and insider sales tied to tax withholding and Rule 10b5-1 plans, have sharpened focus on how media visibility, governance practices, and medical device innovation intersect for this company. Next, we’ll examine how Cramer’s “great, great...

Why Nelnet is on investors’ radar Nelnet (NNI) has been drawing attention after recent share price moves, with the stock last closing at $140.13 as investors weigh its mix of loan servicing, education technology, and banking operations. See our latest analysis for Nelnet. Short term, Nelnet’s share price return has been positive, with an 8.6% 7 day gain and 9.2% 90 day rise. Its 1 year total shareholder return of 37.5% points to sustained momentum rather than a brief spike. If you are looking...

Solowin Holdings (NasdaqCM:AXG) has released its H1 2026 scorecard with trailing 12 month revenue of US$7.7 million and a net loss of US$6.9 million, against a current share price of US$4.18. The company has seen revenue move from US$0.95 million in H2 2024 to US$1.47 million in H1 2025 and US$1.85 million in H2 2025, while basic EPS over those periods shifted from a loss of US$0.38 per share to a loss of US$0.39 and then a smaller loss of US$0.14. For investors, a key consideration is how...

Hyperscale Data, Inc. recently filed an US$8.60 million shelf registration for up to 43,011,836 shares of Class A common stock and confirmed CBIZ CPAs P.C. as its auditor for fiscal 2025, while outlining preliminary year-end asset estimates including cash and Bitcoin holdings. The company’s decision to build a very large Bitcoin treasury relative to its market value, combined with frequent asset-disclosure updates and insider buying, has become a central feature of its evolving investment...

InMode Ltd. recently issued updated earnings guidance, projecting fourth-quarter 2025 revenue of about US$103.6 million to US$103.8 million, full-year 2025 revenue of roughly US$370.2 million to US$370.4 million, and full-year 2026 revenue of US$365 million to US$375 million. This guidance gives investors a clearer view of InMode’s expected revenue trajectory over the next two years, which can be weighed against prior expectations for moderating earnings and margin compression in its...

In recent commentary, SIGA Technologies has been highlighted as a niche biodefense pharmaceutical company with a highly profitable TPOXX antiviral franchise, a strong balance sheet, and contracts primarily with government agencies for smallpox treatment. An interesting angle is how SIGA’s combination of substantial free cash flow, minimal debt, and focus on a single government-backed product is shaping its appeal as a perceived deep-value biodefense play. Next, we’ll examine how SIGA’s...

In late 2025, California Resources Corporation and the Los Angeles Rams marked the first year of their “Football Without the Footprint” partnership, using MiQ-certified low-carbon crude oil, natural gas certificates, and local carbon offsets to reduce and offset the team’s travel and facility emissions. This collaboration positions California Resources as an early mover in pairing traditional energy production with verifiable decarbonization services that deliver local environmental...

What Tanger’s latest SEC filing means for investors Tanger (SKT) has furnished a Form 8-K to the SEC that includes a supplemental information package for the quarter ended September 30, 2025. This filing gives investors updated detail on its outlet and open-air retail portfolio. See our latest analysis for Tanger. Tanger’s latest Form 8-K lands after a steady period for the shares, with the stock at $34.11 and a 90-day share price return of 7.10%, while the 5-year total shareholder return of...

Jamf Holding overview after recent performance shift Jamf Holding (JAMF) has drawn fresh investor attention after a sharp return in the past 3 months, contrasting with weaker results over the past year and multi year period. With shares last closing at US$13.02 and a value score of 5, the stock now sits against a backdrop of modest recent revenue and net income growth, alongside an intrinsic discount estimate of 43.28%. See our latest analysis for Jamf Holding. The recent 28.28% 90-day share...

If you are wondering whether Trustmark at around US$40.09 still offers value, you are not alone. This article walks through what the current price might be implying. The share price has moved 2.6% over the last week, has seen a 1.4% decline over the last month, and is up 23.9% over the past year and 52.6% over five years. This naturally raises questions about how much of the story is already reflected in the price. Recent attention on regional banks has kept investors focused on balance...

If you are wondering whether PotlatchDeltic at around US$43.12 is a fair deal or not, this article will walk through what the current price might be implying about value. The stock has seen returns of 8.6% over the last week, 5.5% over the last month, 8.6% year to date, 17.4% over 1 year, 10.0% over 3 years and 13.1% over 5 years. These figures may have caught the eye of investors thinking about growth potential or shifting risk. Recent coverage has focused on PotlatchDeltic as a US-listed...

If you are wondering whether Globant's current share price reflects its true worth, you are not alone. This article is here to unpack that question in a clear, practical way. The stock last closed at US$68.39, with returns of 8.4% over the past week, a 0.8% decline over 30 days, 8.4% year to date, and declines of 67.0% over 1 year, 59.4% over 3 years, and 67.2% over 5 years. These moves have put Globant back on many investors' watchlists, as the sharp multi year pullback sits alongside a...

If you are wondering whether Lakeland Financial is attractively priced or not, this article walks through what the current numbers might be telling you about the stock. The share price recently closed at US$57.13, with returns of 1.2% over the past week, a 3.7% decline over the past month, 1.2% year to date and a 10.6% decline over the last year, which can shape how investors think about both opportunity and risk. These moves sit against a backdrop of ongoing sector wide attention on...

In recent days, Tecnoglass, a Colombia-based glass and window manufacturer listed on the NYSE, issued full-year EBITDA guidance that disappointed investors, while competitor Apogee Enterprises reported weaker-than-expected third-quarter results and reduced its fiscal 2026 outlook due to softer demand and higher costs. This combination of cautious outlooks has heightened concerns about sector-wide volume and cost pressures, prompting investors to reassess the resilience of Tecnoglass’s...

If you have been wondering whether UL Solutions is priced attractively right now, you are not alone. The stock has drawn attention from investors who are trying to work out what a fair value might look like. The share price last closed at US$84.38, with reported returns of 4.3% over the past week, 9.5% over the past month, and 72.5% over the past year. This naturally raises questions about what is already reflected in the price. Recent coverage has focused on UL Solutions as a newly listed...